Live webinar from Singapore: Portfolio analysis - Go/No-go decisions
Tuesday 3rd December 2019 16:00SGT/16:00CST/17:00JST
When a pharma company is either considering acquiring a new agent, or developing one in-house, marketers need to understand the impact on the overall portfolio and decide whether to make a go or no-go decision on that asset.
Webcast: Portfolio analysis - Tracking for success
Portfolio Analysis and Optimization looks at how honing strategy across multiple agents in the same therapeutic category leads to marketing success. As pharmaceutical companies simultaneously develop and in-license multiple products that can cost millions of dollars, portfolio management is about selecting how to allocate resources and marketing efforts across multiple assets. This has significant impact on the bottom line.
Webcast: Portfolio analysis - Choosing your communication strategy
Portfolio Analysis and Optimization concentrates on determining the impact that multiple assets have within therapeutic categories, and how the marketing of these assets impacts on overall strategy. This is an important tool for pharmaceutical companies in today’s market. As they simultaneously develop multiple products that can become extremely costly, portfolio management to improve decision-making can have a significant impact on the bottom line. At its very core, it is about selecting how to allocate resources and marketing efforts across multiple assets.
Hasta la vista, maybe? Terminating the Hollywood view of AI in pharma
Marketing Director Julie Denny was recently interviewed by PME Magazine about the use of artificial intelligence in pharma marketing and market research.
Rumours that robots will eventually wipe out humans are the futuristic stuff of Hollywood blockbusters. The real-world story arc is much more uplifting but no less dramatic. When a homeless man in central England was crushed to death by a compaction unit as he slept in the dustbin in 2013, it triggered a response from the UK waste management industry that now sees many refuse trucks fitted with senor technology to detect people in bins. It's an early example of how AI can literally save lives. Fast forward six years and we've now got 'robot doctors' detecting cancers, smart remote monitoring systems managing patients miles from their homes and algorithm-led technologies predicting long-term health based on individuals' DNA. The application of AI in health isn't science fiction, it's happening fast - and it’s positively disrupting patient care.
Richard Head presented with MR Excellence award at EphMRA Conference
We were delighted to exhibit, sponsor and present three papers at the EphMRA conference where Director Richard Head was presented with the runner-up award for ‘Business Impact through Innovation’.
Along with Richard Head, Director Paula Coyle and Associate Directors Emilie Braund and An-hwa Lee represented Research Partnership at the three-day annual event, which this year took place at the Hilton Hotel and Convention Centre in Warsaw, Poland.